Mass Spectrometry-Based Multi-Omics Integration Decodes Metabolic-Immune Crosstalk in Multifocal Breast Cancer Progression
Journal of Analysis and Testing · 2026-06 · 10 (2) · 628-641
DOI: 10.1007/s41664-025-00418-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Analysis and Testing, online erschienen am 17.04.2026. Verfasst von Tianyou Cao und 9 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cao, T., Xiao, Y., Yang, Z., Zhou, P., Liu, X., Lv, X., Liu, Y., Tan, X., Zhao, C., & Luo, Q. (2026). Mass Spectrometry-Based Multi-Omics Integration Decodes Metabolic-Immune Crosstalk in Multifocal Breast Cancer Progression. Journal of Analysis and Testing, 10(2), 628-641. https://doi.org/10.1007/s41664-025-00418-2
Vancouver
Cao T, Xiao Y, Yang Z, Zhou P, Liu X, Lv X, et al. Mass Spectrometry-Based Multi-Omics Integration Decodes Metabolic-Immune Crosstalk in Multifocal Breast Cancer Progression. Journal of Analysis and Testing. 2026;10(2):628-641. doi:10.1007/s41664-025-00418-2
BibTeX
@article{Cao2026,
author = {Cao, Tianyou and Xiao, Yu and Yang, Zhiyi and Zhou, Peng and Liu, Xuantong and Lv, Xinwei and Liu, Yashan and Tan, Xiaotian and Zhao, Chao and Luo, Qian},
title = {Mass Spectrometry-Based Multi-Omics Integration Decodes Metabolic-Immune Crosstalk in Multifocal Breast Cancer Progression},
journal = {Journal of Analysis and Testing},
year = {2026},
volume = {10},
number = {2},
pages = {628--641},
doi = {10.1007/s41664-025-00418-2}
}
EUVIMED